Last updated 10 months ago
Drug development is costly and time-consuming, taking up to 10 years & billions of dollars because of fragmented data across institutions, hindering collaboration due to privacy & integrity concerns
This is the total amount allocated to Composable ZK Proofs on Cardano for Bio-Research and Healthcare.
A secure data-sharing protocol on Cardano using MidnightZK enables researchers to democratize drug discovery, accelerating development while safeguarding confidentiality and integrity of data.
No dependencies.
The project will be open source under MIT License. This will allow anyone to do whatever they wish with the original code, as long as the original copyright and license notice is included either in the distributed source code or software.
SDG rating:
SDG Goals
9 - Build resilient infrastructure, promote inclusive and sustainable industrialization and foster innovation
17 - Strengthen the means of implementation and revitalize the Global Partnership for Sustainable Development
SDG Subgoals
17.19 - By 2030, build on existing initiatives to develop measurements of progress on sustainable development that complement gross domestic product, and support statistical capacity-building in developing countries
17.3 - Mobilize additional financial resources for developing countries from multiple sources
9.1 - Develop quality, reliable, sustainable and resilient infrastructure, including regional and transborder infrastructure, to support economic development and human well-being, with a focus on affordable and equitable access for all
9.3 - Increase the access of small-scale industrial and other enterprises, in particular in developing countries, to financial services, including affordable credit, and their integration into value chains and markets
9.b - Support domestic technology development, research and innovation in developing countries, including by ensuring a conducive policy environment for, inter alia, industrial diversification and value addition to commodities
Key Performance Indicator (KPI)
9.1.1 - Proportion of the rural population who live within 2 km of an all-season road
9.1.2 - Passenger and freight volumes, by mode of transport
9.3.1 - Proportion of small-scale industries in total industry value added
9.3.2 - Proportion of small-scale industries with a loan or line of credit
9.b.1 - Proportion of medium and high-tech industry value added in total value added
17.3.1 - Foreign direct investment, official development assistance and South-South cooperation as a proportion of gross national income
17.3.2 - Volume of remittances (in United States dollars) as a proportion of total GDP
17.19.1 - Dollar value of all resources made available to strengthen statistical capacity in developing countries
17.19.2 - Proportion of countries that (a) have conducted at least one population and housing census in the last 10 years; and (b) have achieved 100 per cent birth registration and 80 per cent death registration
A secure data-sharing protocol on the Cardano blockchain, fortified with MidnightZK's zero-knowledge proofs (ZKPs). The protocol facilitates accelerated drug and biotech development by enabling researchers to collaboratively explore datasets while ensuring utmost confidentiality and incentivizations through Cardano NFTs.
We've established a pivotal partnership with Neeta Life Sciences (NLS), spearheaded by Dr. K. Anil Kumar and Dr. G. Gopikrishna, esteemed experts in healthcare solutions and organic chemistry.
Neeta Life Sciences (NLS):
NLS, under the adept leadership of Dr. K. Anil Kumar, a distinguished researcher with over three decades of experience in industrial research. His expertise spans preventive healthcare solutions, nutraceuticals, solid-state formulations (cocrystals), and agri-formulations. Dr. Kumar's robust background in natural product chemistry, biocatalysis, and green chemistry has contributed to over 60 publications and 25 patents, showcasing his significant contributions to science and technology advancement.
Dr. G. Gopikrishna:
Dr. G. Gopikrishna, a seasoned academic and industrial researcher with a Ph.D. in Organic Chemistry from the Indian Institute of Chemical Technology, brings over 23 years of expertise to NLS. His research endeavors in organocatalysis, computational chemistry, and chemical biology have enriched organizations like Dr. Reddy’s Research Foundation, GVK Biosciences, and Chemveda Life Sciences. With numerous publications and patents to his credit, Dr. Gopikrishna's contributions to the field are highly regarded.
This partnership underscores our commitment to harnessing their wealth of knowledge and experience in implementing a low-fidelity Proof of Concept (PoC) for our secure data-sharing protocol on Cardano, reinforcing our shared mission of driving innovation in healthcare and biotech.
Functionality Breakdown:
Technical Overview:
Usecases:
and many more.
Our project contributes to the broader Cardano community in several ways:
Measurement of Impact:
We will measure the impact of our project through quantitative metrics such as adoption interest, the number of healthcare institutions showing interest, and the volume of data shared securely on the platform as POC. Qualitative metrics will include feedback from users and stakeholders on the effectiveness and efficiency of the platform in facilitating collaboration and innovation in healthcare research.
Sharing Outputs and Opportunities:
We are committed to providing ongoing and frequent project updates to the Cardano community through our social media channels, including Discord. Additionally, we will share insights and opportunities resulting from our project through community forums, webinars, and conference presentations. By engaging with the Cardano community and sharing our learnings and successes, we aim to inspire others to leverage Cardano's technology to address challenges in their respective industries.
The team is composed of experts in blockchain technology and financial services with a proven track record for delivering high-quality Cardano-built solutions with transparency and accountability. Our existing products have served to enhance the Cardano ecosystem in a tangible way, we have strong strategic partnerships and we intend to deliver the project with the same level of quality that the Cardano Community has come to expect from us.
With a collective experience of over 30 years in the blockchain domain, our team is well-equipped with the necessary expertise to develop and deliver this project.
Development Team:
Our development team boasts significant expertise in blockchain technology, with a strong focus on the Cardano ecosystem. They have played a pivotal role in several successful projects on Cardano and are skilled in developing dApps on Cardano.
Zero-Knowledge Proofs:
Our team includes pioneers in the Midnight ZK framework, possessing both knowledge and practical experience in applying Zero-Knowledge Proof (ZKP) methodologies.
We've established a pivotal partnership with Neeta Life Sciences (NLS), spearheaded by Dr. K. Anil Kumar and Dr. G. Gopikrishna, esteemed experts in healthcare solutions and organic chemistry.
Neeta Life Sciences (NLS):
NLS, under the adept leadership of Dr. K. Anil Kumar, a distinguished researcher with over three decades of experience in industrial research. His expertise spans preventive healthcare solutions, nutraceuticals, solid-state formulations (cocrystals), and agri-formulations. Dr. Kumar's robust background in natural product chemistry, biocatalysis, and green chemistry has contributed to over 60 publications and 25 patents, showcasing his significant contributions to science and technology advancement.
Dr. G. Gopikrishna:
Dr. G. Gopikrishna, a seasoned academic and industrial researcher with a Ph.D. in Organic Chemistry from the Indian Institute of Chemical Technology, brings over 23 years of expertise to NLS. His research endeavors in organocatalysis, computational chemistry, and chemical biology have enriched organizations like Dr. Reddy’s Research Foundation, GVK Biosciences, and Chemveda Life Sciences. With numerous publications and patents to his credit, Dr. Gopikrishna's contributions to the field are highly regarded.
This partnership underscores our commitment to harnessing their wealth of knowledge and experience in implementing a low-fidelity Proof of Concept (PoC) for our secure data-sharing protocol on Cardano, reinforcing our shared mission of driving innovation in healthcare and biotech.
Outputs:
Acceptance Criteria:
Evidence:
Outputs:
Acceptance Criteria:
Evidence:
A: Milestone Outputs
B: Acceptance Criteria
C: Evidence of Milestone Completion
Final Milestone:
A: Milestone outputs
B: Acceptance criteria
C: Evidence of milestone completion
Rahul Konudula, CEO - Trivolve
He has founded companies across real estate, international commodities, and mineral mining that have been running successfully for more than a decade with 8 figure annual revenue in USD. He has over eight years of experience in the RWA sector, focusing on bringing innovative solutions by integrating AI and Blockchain and consistently being one of the leading contributors to industry advancements in South India.
We are a prominent AI and Blockchain development studio based in Dubai and India, specializing in creating innovative solutions for the Asia-Pacific region. With a dedicated team of 31 professionals, we have been serving over 20 enterprise clients, including governments, venture capital firms, and Fortune 500 companies, for more than three years. Our expertise extends to consulting for leading Cardano projects, leveraging our extensive experience in product development.
Milestone 1
Total Duration: 30 Days
Total: 25000 ADA
Milestone 2
Total Duration: 30 Days
Total: 25000 ADA
Milestone 3
Total Duration: 30 Days
Total: 15000 ADA
Final Milestone: Launch and Reporting
Total Duration: 20 Days
Total: 10000 ADA
Addressing a Critical Need:
Drug discovery suffers from fragmented data and slow collaboration. Our platform tackles this head-on, potentially leading to faster development of life-saving treatments.
Cardano Ecosystem Growth:
Cardano establishes itself as a leader in secure healthcare solutions, attracting new users and developers. Growth and innovation within the Cardano ecosystem, generating returns on investment far exceeding project costs.
We utilize a lean development methodology, emphasizing the prioritization of development and enhancements based on feedback from partners, the community, and users, which ensures efficient and cost-effective use of resources. Our strategic employment of a geographically diverse team spanning the US, Singapore, and India allows us to optimize development costs while upholding high quality and efficiency standards.
This method, along with our dedication to transparency and strategic financial planning, guarantees that the proposal delivers great value for money.